Clinical Trial Update: SWIFT - SWIss Factor XIII Trial in PPH [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for SWIFT, a Factor XIII trial in postpartum hemorrhage currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorder
• Postpartum Hemorrhage

Drugs mentioned

• SWIFT (Factor XIII)

Snippet

Sponsor: Christian Haslinger | Conditions: Postpartum Hemorrhage, Coagulation Disorder | Phase 4 | Status: RECRUITING